Top compounds associated with response to GYPC


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CCLE pan-cancer AAC -0.16 0.03
mRNA Vorinostat GDSC1000 pan-cancer AAC -0.098 0.04
mRNA methylstat CTRPv2 pan-cancer AAC -0.1 0.04
mRNA paclitaxel CTRPv2 pan-cancer AAC -0.084 0.04
mRNA ML006 CTRPv2 pan-cancer AAC -0.095 0.04
mRNA BRD8958 CTRPv2 pan-cancer AAC -0.1 0.04
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.09 0.04
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.04
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.11 0.04
mRNA SKI-II CTRPv2 pan-cancer AAC -0.094 0.04
Download CSV